Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 22 05 2024
accepted: 09 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: epublish

Résumé

Neurological disorders, including multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), may be associated with alterations in blood cell composition and phenotype. Here, we focused our attention on circulating mucosal-associated invariant T (MAIT) cells, a CD8

Identifiants

pubmed: 39108272
doi: 10.3389/fimmu.2024.1436717
pmc: PMC11300250
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1436717

Informations de copyright

Copyright © 2024 De Federicis, Bassani, Chiarelli, Montini, Giordano, Esposito, Riva, Quattrini, Martinelli, Filippi and Farina.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Davide De Federicis (D)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Claudia Bassani (C)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Rosaria Rita Chiarelli (RR)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Federico Montini (F)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

Antonino Giordano (A)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

Federica Esposito (F)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

Nilo Riva (N)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

Angelo Quattrini (A)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Vittorio Martinelli (V)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

Massimo Filippi (M)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
Neurophysiology Service, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Cinthia Farina (C)

Institute of Experimental Neurology and Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH